Astellas has announced that it will be acquiring Audentes Therapeutics at a total cost of $3 billion.
List view / Grid view
Filter the results
The three largest UK political parties have published their manifestos for the upcoming election which focus on various pharma initiatives including the NHS, R&D, drug prices and mental health.
According to a new report, the UK is leading the rest of Europe for early-stage clinical research into new medicines and vaccines, with more than 600 commercial clinical trials taking place in the NHS.
A new report has found that even though ambitions are high in the healthcare sector to invest in digital initiatives, the rate of implementing these initiatives are low.
The ABPI’s Manifesto for Medicine has been issued, calling upon the next government in the UK to work closely with the pharma industry to increase innovation and access to medicines.
500,000 regimens of Janssen's investigational Ebola vaccine are to be donated to support the Ebola outbreak response in the Democratic Republic of the Congo.
A new report has shown that from 2016/17 to 2018/19 clinical research has generated an estimated £8 billion of GVA for the UK.
Research has found that the pharmaceutical industry in India must encourage innovation in order to keep up with the growth of the sector.
Increasing demand for convenient drug delivery, as well as an increase in diseases such as diabetes, has fuelled the global injectable drug delivery market.
King Pharmaceuticals Limited and Alissa Healthcare Research Limited have admitted to sharing information to keep drug prices up.
The global alopecia treatment market is projected to exhibit a CAGR of 4.9 percent from 2018–2026.
According to a new report, pharma companies in India are increasingly entering the Chinese pharma industry through joint ventures.
The pharmaceutical processing and packaging equipment market is expected to witness a high increase during the forecast period (2019-2025).
New investment provides substantial new funding to fuel the next stage of Quotient’s growth.